Healthcare Tracking Study: Driving Smarter Decisions Through Continuous Insight

A global healthcare client needed a robust tracking programme to monitor brand performance, prescribing behaviours, and market dynamics across multiple regions. Existing insight was fragmented and infrequent, limiting the ability to respond to rapid changes in physician attitudes, competitive activity, and treatment pathways.

The client required a tracking approach that would:

• Deliver consistent, comparable KPIs over time
• Provide timely, actionable insights for faster decision-making
• Remain flexible and scalable across markets and therapeutic areas

Bryter designed and implemented a multi-market healthcare tracking study, built around three core principles: Design, Insight, and Repeatability

1. Intelligent Study Design

• Developed a core global framework capturing key brand, behavioural, and attitudinal metrics
• Incorporated modular flexibility to address local market nuances and emerging business questions
• Optimised survey length and structure to maximise engagement and data quality

2. Continuous, Actionable Insight Generation

• Delivered regular tracking waves, providing up-to-date visibility on performance trends
• Combined core KPIs with deeper diagnostic modules to explain shifts in behaviour
• Focused reporting on clear implications and strategic recommendations, not just data

3. Agile and Cost-Effective Execution

• Introduced lighter, pulse-style data collections between major waves to maintain responsiveness
• Leveraged targeted HCP samples to ensure representativeness without unnecessary cost
• Enabled rapid turnaround of key metrics post-fieldwork to support timely decisions

4. Scalable Global Delivery

• Designed the tracker to scale across regions, supporting expansion into additional markets over time
• Ensured consistency in methodology to allow robust cross-market comparisons

The tracking programme became a central decision making tool for the client, delivering:

• Clear visibility of brand performance trends across markets and over time
• Early identification of shifts in prescribing behaviour and competitive pressures
• Improved marketing and engagement strategies, informed by real-world insights
• Faster, more confident decision-making, supported by regular, reliable data reads

The agile structure of the study ensured the client could adapt quickly to market changes, while maintaining a long-term evidence base for strategic planning.

In many markets, the success of the programme led to expansion of the tracker into additional geographies, further increasing its strategic value

Learn more about how market research and insights can build a deeper understanding of the lives of patients, support in testing and development of new therapies and build effective marketing strategies in our 'ultimate guide to pharmaceutical market research and insights'